# A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

> **NCT01096329** · PHASE1 · TERMINATED · sponsor: **VIVUS LLC** · enrollment: 16 (actual)

## Conditions studied

- Hypoactive Sexual Desire Disorder

## Interventions

- **DRUG:** Testosterone Spray 5% and 1%
- **DRUG:** Intrinsa® Patch and Testosterone Spray 5%
- **DRUG:** Intrinsa® Patch and Testosterone Spray 1%

## Key facts

- **NCT ID:** NCT01096329
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-04
- **Final completion:** —
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096329, "A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01096329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*